Abstract

Hydroxychloroquine (HCQ) is an antimalarial agent that is commonly used to treat rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The present report documents a case of hypoglycaemia due to HCQ in a patient with SLE and diabetes mellitus type 2, in which the HCQ completely replaced the need for daily subcutaneous insulin.

Original languageEnglish (US)
JournalBMJ case reports
DOIs
StatePublished - Mar 2 2009

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Hydroxychloroquine: A diabetic drug in disguise?'. Together they form a unique fingerprint.

  • Cite this